Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Zijlstra, J.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(26)
+
-
Other
(2)
+
-
Availability
Open access
(12)
+
-
Metadata Only
(16)
+
-
Creation Date
2021
(5)
+
-
2022
(5)
+
-
2016
(3)
+
-
2017
(3)
+
-
2018
(3)
+
-
2014
(2)
+
-
2020
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(25)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(25)
+
-
Scholarly Publications
(3)
+
-
Topic
Hodgkin lymphoma
(3)
+
-
cardiovascular disease
(2)
+
-
Author
Zijlstra, J.M.
(28)
+
-
Leeuwen, F.E. van
(16)
+
-
Aleman, B.M.P.
(14)
+
-
Schaapveld, M.
(13)
+
-
Krol, A.D.G.
(12)
+
-
Janus, C.P.M.
(11)
+
-
Maazen, R.W.M. van der
(11)
+
-
Eggermond, A.M. van
(9)
+
-
Lugtenburg, P.J.
(9)
+
-
Boer, J.P. de
(8)
+
-
Vermaat, J.S.P.
(7)
+
-
Visser, O.
(7)
+
-
Imhoff, G.W. van
(6)
+
-
Krul, I.M.
(6)
+
-
Bakhshi, S.
(5)
+
-
Beijert, M.
(5)
+
-
Cavallo, F.
(5)
+
-
Choquet, S.
(5)
+
-
Follows, G.
(5)
+
-
Gurion, R.
(5)
+
-
Hamad, N.
(5)
+
-
Jaeger, U.
(5)
+
-
Kalakonda, N.
(5)
+
-
Kersten, M.J.
(5)
+
-
Maerevoet, M.
(5)
+
-
Raemaekers, J.M.M.
(5)
+
-
Roesink, J.M.
(5)
+
-
Thieblemont, C.
(5)
+
-
Warzocha, K.
(5)
+
-
Casasnovas, R.O.
(4)
+
-
Chamuleau, M.E.D.
(4)
+
-
Egyed, M.
(4)
+
-
Goy, A.
(4)
+
-
Hauptmann, M.
(4)
+
-
Hill, B.
(4)
+
-
Kremer, L.C.M.
(4)
+
-
Kuruvilla, J.
(4)
+
-
Louwman, M.W.J.
(4)
+
-
Lybeert, M.L.
(4)
+
-
Ma, X.W.
(4)
+
-
Mous, R.
(4)
+
-
Neste, E. van den
(4)
+
-
Nijland, M.
(4)
+
-
Offner, F.
(4)
+
-
Russell, N.S.
(4)
+
-
Sancho, J.M.
(4)
+
-
Schuster, M.
(4)
+
-
Shacham, S.
(4)
+
-
Vassilakopoulos, T.P.
(4)
+
-
Bakunina, K.
(3)
+
-
Broeks, A.
(3)
+
-
Bruin, M.L. de
(3)
+
-
Caimi, P.
(3)
+
-
Canales, M.
(3)
+
-
Chamoun, K.
(3)
+
-
Corona, K.
(3)
+
-
Cruz, F. de la
(3)
+
-
Daniels, L.A.
(3)
+
-
Diallo, I.
(3)
+
-
Fase, S.
(3)
+
-
Jong, D. de
(3)
+
-
Kauffman, M.G.
(3)
+
-
Kesminiene, A.
(3)
+
-
Kooijman, K.R.
(3)
+
-
Lugtenburg, P.
(3)
+
-
Lybeert, M.
(3)
+
-
Poortmans, P.M.P.
(3)
+
-
Samal, P.
(3)
+
-
Shah, J.
(3)
+
-
Vathaire, F. de
(3)
+
-
Beijert, M.L.
(2)
+
-
Bohmer, L.H.
(2)
+
-
Bouabdallah, R.
(2)
+
-
Brink, M.
(2)
+
-
Canales, M.A.
(2)
+
-
Clevers-Petersen, E.J.
(2)
+
-
Diepstra, A.
(2)
+
-
Dierickx, D.
(2)
+
-
Durmaz, M.
(2)
+
-
Eggermond, A.M.
(2)
+
-
Hoekstra, O.
(2)
+
-
Huls, G.
(2)
+
-
Imhoff, G. van
(2)
+
-
Jongh, E. de
(2)
+
-
Kremer, L.C.
(2)
+
-
Ku, M.
(2)
+
-
Ku, M.T.
(2)
+
-
Leerdam, M.E. van
(2)
+
-
Louwman, M.J.
(2)
+
-
Mandigers, C.
(2)
+
-
Marijt, E.W.A.
(2)
+
-
Meerten, T. van
(2)
+
-
Mulder, I.
(2)
+
-
Nijziel, M.R.
(2)
+
-
Opstal-van Winden, A.W.J.
(2)
+
-
Petersen, E.J.
(2)
+
-
Plattel, W.J.
(2)
+
-
Poortmans, P.M.
(2)
+
-
Posthuma, E.F.M.
(2)
+
-
Raemaekers, J.
(2)
+
-
Roesink, J.
(2)
+
-
Saint-Martin, J.R.
(2)
+
-
Smits, M.
(2)
+
-
Sonke, G.S.
(2)
+
-
Spronsen, D.J. van
(2)
+
-
Vermaat, J.
(2)
+
-
Show more
Language
en
(28)
+
-
Search results
(1 - 24 of 28)
Pages
1
2
›
››
show grid
show list
save search
R-miniCHOP versus R-CHOP in elderly patients with diffuse large B-cell lymphoma
Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma
Detection and localization of early- and late-stage cancers using platelet RNA
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage
The association between patient characteristics and the efficacy and safety of selinexor in diffuse large B-cell lymphoma in the SADAL study
Comparison of the effectiveness and safety of the oral selective inhibitor of nuclear export, selinexor, in diffuse large B cell lymphoma subtypes
Light therapy for cancer-related fatigue in (non-)Hodgkin lymphoma survivors
Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma
Neurocognitive functioning and radiologic changes in primary CNS lymphoma patients
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study
Long-term cause-specific mortality in Hodgkin lymphoma patients
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide
Selinexor in patients with relapsed or refractory diffuse large B -cell lymphoma (SADAL): a single -arm, multinational, multicentre, open -label, phase 2 trial
Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer
Single Agent Oral Selinexor Demonstrates Deep and Durable Responses in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) in Both GCB and Non GCB Subtypes: The Phase 2b Sadal Study
Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial
Rationale and design of a cohort study on primary ovarian insufficiency in female survivors of Hodgkin's lymphoma: influence on long-term adverse effects (SOPHIA)
Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors
Breast cancer after Hodgkin lymphoma: Influence of endogenous and exogenous gonadal hormones on the radiation dose-response relationship
AN UPDATE ON BETER, THE DUTCH NATIONWIDE SURVIVORSHIP CARE PROGRAMME FOR HODGKIN LYMPHOMA SURVIVORS
CAUSE-SPECIFIC MORTALITY AMONG HODGKIN LYMPHOMA PATIENTS UP TO 40 YEARS AFTER TREATMENT
BREAST CANCER AFTER HODGKIN LYMPHOMA: INFLUENCE OF ENDOGENOUS AND EXOGENOUS GONADAL HORMONES ON THE RADIATION DOSE-RESPONSE RELATIONSHIP
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Pages
1
2
›
››